Come up with a name for your new list and we'll add to it:
CytoPherx raised a round of funding on October 22, 2007. Investors include
Dow Employees Pension Plan.
CytoPherx, formerly Nephrion, is a clinical stage medical device company addressing inflammation based diseases and conditions with a selective cytopheresis-based inflammation modulating system.…